JP2012506031A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506031A5
JP2012506031A5 JP2011531396A JP2011531396A JP2012506031A5 JP 2012506031 A5 JP2012506031 A5 JP 2012506031A5 JP 2011531396 A JP2011531396 A JP 2011531396A JP 2011531396 A JP2011531396 A JP 2011531396A JP 2012506031 A5 JP2012506031 A5 JP 2012506031A5
Authority
JP
Japan
Prior art keywords
biglycan
marker
risk
individual
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011531396A
Other languages
English (en)
Japanese (ja)
Other versions
JP5528461B2 (ja
JP2012506031A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/007399 external-priority patent/WO2010043393A1/en
Publication of JP2012506031A publication Critical patent/JP2012506031A/ja
Publication of JP2012506031A5 publication Critical patent/JP2012506031A5/ja
Application granted granted Critical
Publication of JP5528461B2 publication Critical patent/JP5528461B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011531396A 2008-10-17 2009-10-15 心不全の評価におけるビグリカンの使用 Expired - Fee Related JP5528461B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08018196 2008-10-17
EP08018196.9 2008-10-17
PCT/EP2009/007399 WO2010043393A1 (en) 2008-10-17 2009-10-15 Use of biglycan in the assessment of heart failure

Publications (3)

Publication Number Publication Date
JP2012506031A JP2012506031A (ja) 2012-03-08
JP2012506031A5 true JP2012506031A5 (enExample) 2012-07-05
JP5528461B2 JP5528461B2 (ja) 2014-06-25

Family

ID=40418863

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011531396A Expired - Fee Related JP5528461B2 (ja) 2008-10-17 2009-10-15 心不全の評価におけるビグリカンの使用

Country Status (6)

Country Link
US (1) US20110165591A1 (enExample)
EP (1) EP2347265A1 (enExample)
JP (1) JP5528461B2 (enExample)
CN (1) CN102187228A (enExample)
CA (1) CA2738417A1 (enExample)
WO (1) WO2010043393A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107110871B (zh) * 2014-10-29 2019-09-27 豪夫迈·罗氏有限公司 用于死亡的风险预测的生物标志物
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
CN115236340A (zh) * 2022-07-28 2022-10-25 复旦大学附属中山医院 S100a4、s100a8/a9和s100a12作为扩张型心肌病生物标记物的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654270A (en) * 1988-06-28 1997-08-05 La Jolla Cancer Research Foundation Use of fibromodulin to prevent or reduce dermal scarring
DE3922873A1 (de) * 1989-04-25 1990-10-31 Boehringer Mannheim Gmbh Spezifische antikoerper gegen troponin t, ihre herstellung und verwendung in einem reagenz zur bestimmung von hermuskelnekrosen
US6333397B1 (en) * 1989-04-25 2001-12-25 Roche Diagnostics Gmbh Monoclonal antibodies to troponin T and their production
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
ATE281648T1 (de) * 1995-04-18 2004-11-15 Biosite Diagnostics Inc Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays
US6610480B1 (en) * 1997-11-10 2003-08-26 Genentech, Inc. Treatment and diagnosis of cardiac hypertrophy
US20090233270A9 (en) * 2000-08-02 2009-09-17 St Croix Brad Secreted and cytoplasmic tumor endothelial markers
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US6461828B1 (en) * 2001-09-04 2002-10-08 Syn X Pharma Conjunctive analysis of biological marker expression for diagnosing organ failure
GB0216191D0 (en) * 2002-07-11 2002-08-21 Univ Leicester Plasma urotensin in human heart failure
MXPA06005950A (es) * 2003-11-25 2006-07-06 Novartis Ag Biomarcadores para determinar la eficacia del tratamiento con calcitonina y hormona paratiroides.
WO2006034356A2 (en) 2004-09-20 2006-03-30 The Board Of Trustees Of The Leland Stanford Junior University Cardiac pressure overload associated genes
EP1929295A4 (en) * 2005-08-30 2010-03-17 Biosite Inc USE OF SOLUBLE FLT-1 AND ITS FRAGMENTS IN CARDIOVASCULAR CONDITIONS
EP1837659B1 (en) * 2006-03-24 2010-06-09 F. Hoffman-la Roche AG Means and methods for the differentiation of acute and chronic myocardial necrosis in symptomatic patients
US20100143949A1 (en) * 2006-10-31 2010-06-10 George Mason Intellectual Properties, Inc. Biomarkers for colorectal cancer
HU0700024D0 (en) * 2007-01-11 2007-03-28 Mta Szegedi Biolog Koezpont Use of enhancers in biglycan activuty in the preparation of pharmaceutical compositions having utility in cardiac diseases
DE102007010834A1 (de) * 2007-03-03 2008-09-04 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz für NYHA I Patienten

Similar Documents

Publication Publication Date Title
JP2011528458A5 (enExample)
DK3309139T3 (da) Process for the preparation of 2,3,3,3-trifluoropropene
EP2349097C0 (en) IMPROVED ARTIFICIAL VALVE
JP2013521366A5 (enExample)
BRPI1008902A2 (pt) válvula cardíaca protética.
BRPI0920428A2 (pt) inalador.
JP2013525942A5 (enExample)
IL241752A0 (en) Method of monitoring patient compliance
JP2011526809A5 (enExample)
JP2011523810A5 (enExample)
DK2338287T3 (da) Transducersystem
JP2012506031A5 (enExample)
BRPI0915524A2 (pt) conjunto de aerofólio
BRPI1011134A2 (pt) turbomáquina.
FI20085171L (fi) Uudet selluloosajohdannaiset, menetelmä niiden valmistamiseksi sekä niiden käyttö
JP2011004745A5 (enExample)
JP2011525472A5 (enExample)
JP2007320968A5 (enExample)
JP2013536184A5 (enExample)
JP2010528620A5 (enExample)
BRPI1013323A2 (pt) "indicador de umidade, matriz de indicador de umidade, método de indicação de umidade, e, método para preparar um indicador de umidade."
DK2245463T3 (da) Diagnostisk fremgangsmåde
DK2387349T3 (da) Fremgangsmåde til inspektion af indersiden af en snæver slange eller et snævert rør, især til medicinsk brug
FR2914192B1 (fr) Sonde respiratoire.
JP2013251736A5 (enExample)